Sab Biotherapeutics (SABS)'s 30-day implied volatility (IV30) was 83.6% at the close on November 6, 2026, up from 78.2% the day before, against a 52-week range of 47.8% to 155.0%. Its 20-day historical volatility was 82.5%.
Data as of November 6, 2026.